Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer - Concepedia

Concepedia

Publication | Closed Access

Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer

687

Citations

21

References

2005

Year

Fairooz F. Kabbinavar, Julie Hambleton, R. Mass, Herbert I. Hurwitz, Emily K. Bergsland, Somnath Sarkar

Journal of Clinical Oncology

Abstract

The addition of bevacizumab to FU/LV provides a statistically significant and clinically relevant benefit to patients with previously untreated metastatic colorectal cancer.

References

	Year	Citations

Page 1